Long-term Insulin vs Liraglutide Effect on Beta-cell Function in Type 1 Diabetes with Residual Insulin Secretion-Extension Study

Trial Profile

Long-term Insulin vs Liraglutide Effect on Beta-cell Function in Type 1 Diabetes with Residual Insulin Secretion-Extension Study

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Liraglutide (Primary) ; Insulins
  • Indications Type 1 diabetes mellitus
  • Focus Expanded access; Therapeutic Use
  • Acronyms SAVE-ISLET Extension Study
  • Most Recent Events

    • 04 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 05 Oct 2012 Results from the initial trial presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top